First Trust Advisors
IRON icon

First Trust Advisors’s Disc Medicine IRON Stock Holding History

First Trust Advisors’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,246
Closed -$543K – 2659
2025
Q2 		$543K Buy
+10,246
New +$481K ﹤0.01% 2242

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors's IRON Position: Q3 2025 in Review

First Trust Advisors sold out of Disc Medicine (IRON) in Q3 2025, closing a stake of 10,246 shares — an estimated $543K sold.

First Trust Advisors first reported a position in IRON in Q2 2025 and held it in 1 quarter. The position peaked at $543K in Q2 2025. 168 funds tracked by Wall St. Rank hold IRON as of Q3 2025.

  • First Trust Advisors reported no remaining Disc Medicine position as of Q3 2025 after selling out during the quarter.
  • First Trust Advisors sold 10,246 Disc Medicine shares in Q3 2025, an estimated $543K.
  • First Trust Advisors first reported a position in Disc Medicine in Q2 2025 and held it in 1 quarter.
  • First Trust Advisors's Disc Medicine position peaked at $543K in Q2 2025.
  • 168 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2025.

Based on First Trust Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.